drugset / Trial / NCT00623207

Use of Atropine in Tredmill Stress Testing

NCT00623207

Phase 3 Completed 103 enrolled HaEmek Medical Center, Israel
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The aim of this study is to evaluate the Safety and feasibility of atropine added during treadmill stress testing in patients with chronotropic incompetence or poor exercise capacity. Our hypothesis is that we can increase heart rate by using atropin in these patients, so we will achieve more conclusive results.

Timeline

Start
2007-12
Primary completion
2009-10
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 0.5 mg Intravenous
Comparator Atropine Other / unclassified 2 mg Intravenous